Results 81 to 90 of about 4,684,020 (381)

Szolvenciatőke mint fixpont (Solvency Capital as a Fixpoint) [PDF]

open access: yes, 2014
A tanulmányban a szerző a fixpont-iteráció témájával foglalkozik egy elméleti modellben, a biztosítók szolvenciatőkéjének számolásával kapcsolatban. A téma aktualitását a biztosítók tőkemegfelelésével összefüggő Szolvencia II.
Szüle, Borbála
core  

A Comparative Analysis Of The Effectiveness Of Three Solvency Management Models [PDF]

open access: yes, 2008
The introduction of the Altman’s Z-score model in 1983 and much recently the Enyi’s Relative Solvency Ratio model in 2005 has divergently provided financial analysts with alternative methods of analyzing corporate solvency which hitherto was ...
Enyi , P. E.
core   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

open access: yesMolecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala   +15 more
wiley   +1 more source

Assessment of the Stability of Insurance Companies: The Case of Baltic Non-Life Insurance Market

open access: yesEconomics and Business, 2018
The study gives an overview of the Baltic non-life insurance market. The purpose of the research is to summarise stability statistics on solvency ratios, risk profiles and capital surplus, which was contained in Solvency and Financial Condition reports ...
Zariņa Ilze   +2 more
doaj   +1 more source

Ryzyko zakładów ubezpieczeń w świetle nowych wymogów kapitałowych Solvency II

open access: yesProblemy Zarządzania, 2013
The aim of this work is to conduct the key aspects of a heated debate about effects and issues connected with implementing a new solution of risk management in insurance companies included in Solvency II.
Teresa Czerwińska
doaj   +1 more source

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

open access: yesMolecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung   +17 more
wiley   +1 more source

Investment Potential of Insurance Companies: Ukrainian and European Experience [PDF]

open access: yesProblemi Ekonomiki
The article examines the investment potential of insurance companies as a factor in stabilizing the country’s financial system. The main focus is on analyzing the regulatory requirements in the European Union and the possibilities for their ...
Liutyi Ihor O. , Lialkin Oleksandr S.
doaj   +1 more source

Hands‐on protocol for preparing water‐soluble fractions from agri‐food samples for NMR‐based metabolomics analysis

open access: yesFEBS Open Bio, EarlyView.
This research protocol outlines a workflow for nuclear magnetic resonance (NMR)‐based metabolomics in the agri‐food sector. Using two case studies—strawberry leaves (solid matrix) and wine (liquid matrix)—it details the procedures for sample preparation, data acquisition, and processing.
Andrea Fernández‐Veloso   +4 more
wiley   +1 more source

Some Comments on QIS3. [PDF]

open access: yes
In this paper we discuss some issues proposed in the Solvency II - QIS3 report. In particular we comment and discuss the \AISAM-ACME study on non-life long tail liabilities; reserve risk and risk margin assessment under Solvency II".
Dhaene, Jan   +2 more
core  

Home - About - Disclaimer - Privacy